BL
KITE

BCWM LLC’s Kite Pharma, Inc. KITE Stock Holding History

BCWM LLC’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,203
Closed -$570K – 77
2016
Q3 		$570K Buy
10,203
+178
+2% +$9.92K 0.27% 57
2016
Q2 		$501K Buy
10,025
+165
+2% +$8.11K 0.24% 57
2016
Q1 		$453K Buy
+9,860
New +$478K 0.25% 65

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

BCWM LLC's KITE Position: Q4 2016 in Review

BCWM LLC sold out of Kite Pharma, Inc. (KITE) in Q4 2016, closing a stake of 10,203 shares — an estimated $570K sold.

BCWM LLC first reported a position in KITE in Q1 2016 and held it in 3 quarters. The position peaked at $570K in Q3 2016. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

  • BCWM LLC reported no remaining Kite Pharma, Inc. position as of Q4 2016 after selling out during the quarter.
  • BCWM LLC sold 10,203 Kite Pharma, Inc. shares in Q4 2016, an estimated $570K.
  • BCWM LLC first reported a position in Kite Pharma, Inc. in Q1 2016 and held it in 3 quarters.
  • BCWM LLC's Kite Pharma, Inc. position peaked at $570K in Q3 2016.
  • 184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on BCWM LLC's 13F filing for Q4 2016, filed 9 Feb 2017.